John Tischio
University of Rochester
3 Papers
11 Citations
John Tischio is an academic researcher from University of Rochester. The author has contributed to research in topics: Peptide sequence & Radioimmunoassay. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Short in vitro half‐life of thymopoietin 32–36 pentapeptide in human plasma
TL;DR: The data imply that the pentapeptide, which is active in vivo, may rapidly trigger changes in responsive cells; sustained circulating levels may not be required for activity.
66
Solid-phase synthesis and degradation of a model polypeptide by an automated approach.
TL;DR: The automated solid-phase degradation of naturally occurring polypeptides and proteins should be possible through modifications of the described approach.
9
Bromperidol radioimmunoassay: Human plasma levels
TL;DR: Cross-reactivity characteristics of the antisera indicated that dehydrobromperidol could significantly interfere with the RIA procedure, however, biotransformation studies have not suggested this compound as a metabolite of brom peridol.
2